![[TXT]](/icons/text.gif) 140sf.0910-1 Sex specific trends in midlife CHD risk and prevalence (Towfighi, Arch Intern Med)_s.pdf | 80.71Kb | October 28 2009 |
| 140sf.0910-3 Women's CV health (Oertelt-Prigione, Arch Intern Med)_s.pdf | 110.44Kb | October 28 2009 |
| 20.0910-Time is of the Essence. Vascular implications of the Circadian Clock (Rudic, Circulation)_s.pdf | 339.63Kb | October 28 2009 |
| 213.0910-Habitual physical activity reduces the risk of ischemic stroke. Case-control study (Liang, CVD)_s.pdf | 126.48Kb | October 28 2009 |
| 213.0910-Is there a decline in the vascular event rate after TIA or stroke in antiplatelet trials (Lemmens, CVD)_s.pdf | 221.87Kb | October 28 2009 |
| 213.0911-1 Statin Tt and Stroke outcome in SPARCL trial (Goldstein, Stroke)_s.pdf | 288.72Kb | October 28 2009 |
| 213.0911-2 Statins prevent stroke recurrences ...but can they improve stroke outcomes (Rabinstein, Stroke)_s.pdf | 148.61Kb | October 28 2009 |
| 222.0911-Recommendations for imaging acute ischemic stroke (AHA, Stroke)_s.pdf | 364.79Kb | October 28 2009 |
| 223.0911-Usefulness of ABCD2 score to distinguish TIA & minor strokes from non-cerebrovascular events (Sheehan, Stroke)_s.pdf | 240.26Kb | October 28 2009 |
| 244.0911-Falsely claiming use of NASCET percentage stenosis method. (Fox, Radiology) Letter +++_s.pdf | 53.62Kb | October 29 2009 |
| 255.0910-The GALA trial, Will it influence clinical practice (Paraskvas, Vasc Endovasc Surg)_s.pdf | 108.70Kb | October 23 2009 |
| 255.0911-Comparative effectiveness of CAS vs EAE (Groeneveld, jvs)_s.pdf | 361.02Kb | November 2 2009 |
| 318.0910ep-Prediction rule for CV events and mortality in PAD patients. SMART (Sprengers, jvs)_s.pdf | 360.61Kb | November 2 2009 |
| 325.0910ep-Management of diabetic foot problems (Kalish, jvs)_s.pdf | 182.48Kb | November 2 2009 |
| 335.0910ep-Amputations in PAD patients. German Federal Statistical Office (Gutacker, Vasc Med)_s.pdf | 162.34Kb | October 23 2009 |
| 350.0911-Contemporary management of AthS renovascular disease (Edwards, jvs)_s.pdf | 170.30Kb | November 2 2009 |
| 377s.0911-Endoleak after EVAR, DUS is better than CT at determining the need for intervention (Schmieder, jvs)_s.pdf | 508.47Kb | November 2 2009 |
| 418.0909-Cold damage of the extremities, frosbite and non-freezing cold injuries (Imray, PGMJ)_s.pdf | 968.24Kb | September 18 2009 |
| 493an.0910ep-Prevalence, RF, and clinical correlates of ulnar artery occlusion in the general population (Carpentier, jvs)_s.pdf | 293.83Kb | November 2 2009 |
| 621n.0911-Neurological outcomes in patients with IS receiving Enoxaparin or Heparin for VTE prophylaxis (Kase, Stroke)_s.pdf | 257.24Kb | October 28 2009 |
| 622ot.0911-Fondaparinux for VTE prevention in HR trauma patients. Pilot study (Lu, J Am Coll Surg)_s.pdf | 186.60Kb | November 2 2009 |
| 642d.0910ep-Isolated gastrocnemius and soleal DVT. Should these patients receive AC (Lautz, Ann Surg)_s.pdf | 961.80Kb | October 28 2009 |
| 648.0911-DD levels and 15-d outcome in acute PE. RIETE registry (Lobo, JTH)_s.pdf | 106.17Kb | November 2 2009 |
| 671c.0911-Attitude to prescribing ECS for patients with acute DVT. MASTER registry (Arpaia, JTT)_s.pdf | 165.92Kb | October 28 2009 |
| 673.0911-DD to determine AC duration, risk of CV event and occult Kc after a 1st idiopathic VTE. Extended PROLONG (Cosmi, JTT)_s.pdf | 189.21Kb | October 28 2009 |
| 677.0908-Development of persistent thrombotic masses in patients with DVT randomized to long-term AC Tt (Vitovec, Vasa)_s.pdf | 607.19Kb | October 29 2009 |
| 72.0911-Platelet functions beyond hemostasis (Smyth, JTH)_s.pdf | 240.20Kb | October 24 2009 |
| 766a.0911-Tt of recurrent VV of the GSV by conventional surgery and EVLA (Groenendael, jvs)_s.pdf | 147.78Kb | November 2 2009 |
| 820.0911-Saccular neck venous aneurysm on CDUS, 12 cases (Wen, Clin Imag)_s.pdf | 3.84Mb | November 2 2009 |
| 911.0910-2 Sex differences in mortality after acute MI (Vaccarino, Arch Intern Med)_s.pdf | 181.72Kb | October 28 2009 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory